Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade
- 18 May 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 194 (3) , 327-333
- https://doi.org/10.1002/path.910
Abstract
There is increasing evidence that there are different progression routes leading to invasive breast cancer, depending on histology and differentiation grade. The aim of this study was to determine alterations in the expression of proteins involved in proliferation and apoptosis in non-invasive and invasive ductal breast lesions. Immunohistochemistry was performed on 106 usual ductal hyperplasias (UDH), 61 DCIS lesions and 53 invasive ductal breast carcinomas. Increased proliferation (Ki67), overexpression of cyclin D1, HER-2/neu, p21 and p53, and decreased expression of bcl-2 and p27 could already be found in UDH. Significant differences between UDH and DCIS lesions were found for only one protein when UDH was compared with well-differentiated DCIS (p27), for three proteins when compared with intermediately differentiated DCIS (p21, cyclin D1, Ki-67), and for all proteins when compared with poorly-differentiated DCIS. Comparing DCIS with invasive lesions of same differentiation grade, proliferation was elevated in the invasive lesions. Altered expression of the other proteins was in general only slightly increased in the invasive lesion compared with DCIS. The number of proteins with altered expression per lesion was highest in poorly-differentiated lesions and was comparable between DCIS and invasive cancer of the same differentiation grade. In conclusion, the biggest changes in expression of these proliferation and apoptosis related proteins appear to occur during the transition from hyperplasia to DCIS; they probably play a minor role in the transition from DCIS to invasive breast lesion of same differentiation grade. Well-differentiated in situ and invasive breast lesions share many of the aberrations in expression of these proteins, as do poorly-differentiated in situ and invasive lesions. However, there are many differences between the well and poorly-differentiated lesions. This further supports the existence of different progression routes leading to breast cancer. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 39 references indexed in Scilit:
- Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomasMolecular Pathology, 1999
- The transition from hyperplasia to invasive carcinoma of the breastThe Journal of Pathology, 1999
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survivalBritish Journal of Cancer, 1996
- PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRESSION OF p53 AND c-erbB-2 PROTEINS IN BREAST CANCERThe Journal of Pathology, 1996
- A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancerBritish Journal of Cancer, 1996
- Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosisThe Journal of Pathology, 1995
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992